RecruitingPhase 2NCT05683808
Venous Thromboembolism Prevention in Outpatients With Glioma
Studying High-grade astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Vermont Medical Center
- Principal Investigator
- Alissa A Thomas, MD, MDUniversity of Vermont Medical Center
- Intervention
- Apixaban(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- University of Vermont Medical Center, Burlington, Vermont, United States
Collaborators
Dartmouth-Hitchcock Medical Center · MaineHealth
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05683808 on ClinicalTrials.govOther trials for High-grade astrocytoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07551336Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGNCT06214689IDH1 and OCT4 in High Grade AstrocytomaAssiut University
- RECRUITINGNANCT05979064Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)Northwell Health